The U.S. Preventive Services Task Force withheld a recommendation for screening children under 18 who don’t have diabetes symptoms due to a lack of evidence, saying it cannot adequately assess the benefits and harms of such screenings.
About 22 to 52 percent of children under the age of 18 with prediabetes return to normal glycemia or glucose tolerance without intervention within two years, the task force said.
“Because some youth with prediabetes may revert to normal glycemia without intervention, potential harms of screening include labeling, overdiagnosis, and overtreatment,” the group wrote in its recommendation statement published in JAMA.
View the full recommendation here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
